Advertisement

Topics

CAR-T Competition Heats Up with a New IND Approval

06:35 EST 9 Mar 2017 | Labiotech.eu

The FDA has cleared an IND application to Servier to set sail in clinical development of UCART19, an allogeneic CAR-T cell therapy developed by Cellectis. The French company Cellectis is developing off-the-shelf CAR-T therapies for cancer. Hot on the heels of its ...

This awesome article CAR-T Competition Heats Up with a New IND Approval appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: CAR-T Competition Heats Up with a New IND Approval

NEXT ARTICLE

More From BioPortfolio on "CAR-T Competition Heats Up with a New IND Approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...